Validation of the 70-Gene Signature Test (MammaPrint) to Identify Patients With Breast Cancer Aged ≥70 Years With Ultralow Risk of Distant Recurrence
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Geriatric Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Validation of the 70-gene signature test (MammaPrint) to identify patients with breast cancer aged ≥ 70 years with ultralow risk of distant recurrence: A population-based cohort study
J Geriatr Oncol 2022 Jul 21;[EPub Ahead of Print], I Noordhoek, E Bastiaannet, NA de Glas, J Scheepens, LJ Esserman, J Wesseling, AN Scholten, CP Schröder, SG Elias, JR Kroep, JEA Portielje, M Kleijn, GJ LiefersFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.